Literature DB >> 6243096

Progestin receptors in rat brain: distribution and properties of cytoplasmic progestin-binding sites.

N J MacLusky, B S McEwen.   

Abstract

Putative progestin receptors have been characterized in brain and pituitary tissue from untreated and estrogen-primed ovariectomized-adrenalectomized rats. The properties of these sites appear indistinguishable from those of cytoplasmic progestin receptors from the uterus: 1) sedimentation coefficient of 7S, which is reduced by half in the presence of 0.3 M KCl; 2) specificity of binding which strongly favors synthetic and natural progestins as opposed to glucocorticoids, androgens, and estrogens; 3) a dissociation constant for binding the synthetic progestin [3H]R5020 (17 alpha, 21-dimethyl-19-norpregna-4, 9-diene-3,20-dione) of 0.3 nM; and 4) similar rates of formation and dissociation of the [3H]R5020-receptor complexes. In these respects, the estrogen-inducible and noninducible receptors of the brain also appear to be indistinguishable from each other. Estrogen induction of progestin receptors is apparent in uterus (6-fold), pituitary (8-fold), mediobasal hypothalamus (4-fold), and preoptic area (4-fold), all estrogen receptor-containing areas. The corticomedial amygdala does not show an estrogen effect on progestin receptor levels even though it contains estrogen receptor sites. The midbrain of the rat doeogen-insensitive receptors in the brain is relatively low and of the same order of magnitude as in nonstimulated hypothalamus, preoptic area, and pituitary, yet variations are seen among the estrogen-insensitive structures, with lowest levels occurring in cerebellum (6-7 fmol/mg protein) and highest levels occuring in cerebral cortex (approximately 25 fmol/mg protein). These findings are discussed in relation to the actions of progesterone which do and do not require estrogen priming and in relation to intracranial progesterone implantation studies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6243096     DOI: 10.1210/endo-106-1-192

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  31 in total

Review 1.  Progesterone and neuroprotection.

Authors:  Meharvan Singh; Chang Su
Journal:  Horm Behav       Date:  2012-06-23       Impact factor: 3.587

2.  A Kiss and a PRomise.

Authors:  Kimberly H Cox
Journal:  Endocrinology       Date:  2015-09       Impact factor: 4.736

Review 3.  The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female.

Authors:  Helen E Scharfman; Neil J MacLusky
Journal:  Epilepsia       Date:  2006-09       Impact factor: 5.864

Review 4.  Progestin receptor subtypes in the brain: the known and the unknown.

Authors:  Shaila Mani
Journal:  Endocrinology       Date:  2008-02-28       Impact factor: 4.736

Review 5.  Sex steroidal hormones and respiratory control.

Authors:  Mary Behan; Julie M Wenninger
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

6.  Extrahypothalamic effects of melatonin administration on serotonin and norepinephrine synthesis in female Syrian hamsters.

Authors:  N A Alexiuk; J P Vriend
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 7.  Estradiol signaling in the regulation of reproduction and energy balance.

Authors:  Kevin Sinchak; Edward J Wagner
Journal:  Front Neuroendocrinol       Date:  2012-09-07       Impact factor: 8.606

Review 8.  Patterns of steroid hormone effects on electrical and molecular events in hypothalamic neurons.

Authors:  D W Pfaff
Journal:  Mol Neurobiol       Date:  1989       Impact factor: 5.590

Review 9.  Extranuclear signaling by ovarian steroids in the regulation of sexual receptivity.

Authors:  Paul E Micevych; Kevin Sinchak
Journal:  Horm Behav       Date:  2018-05-18       Impact factor: 3.587

10.  Estradiol and progesterone differentially regulate the dendritic arbor of neurons in the hypothalamic ventromedial nucleus of the female rat (Rattus norvegicus).

Authors:  Gerald D Griffin; Loretta M Flanagan-Cato
Journal:  J Comp Neurol       Date:  2008-10-20       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.